<DOC>
	<DOCNO>NCT01150266</DOCNO>
	<brief_summary>This pilot study thrombolytic therapy patient ischemic stroke present stroke symptom upon awaken .</brief_summary>
	<brief_title>Study Use Alteplase Patients Who Awaken With Stroke</brief_title>
	<detailed_description>Patients ischemic stroke currently eligible treatment intravenous thrombolysis stroke diagnose within 4.5 hour know onset symptom . Many patient awaken stroke exclude therapy , follow current guideline . Patients suffer stroke waking may candidate thrombolysis study use advance neuroimaging select patient .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>1 . Age ≥22 2 . Stroke upon awaken 3 . Measurable deficit NIHSS 4 . No deficit sleep last see normal sleep 5 . Head CT evidence intracranial hemorrhage . 6 . Able receive IV tPA treatment within 2.5 hrs patient awake deficit . 7 . Written inform consent sign date patient ( patient 's authorized representative ) 8 . Core lesion : ASPECTS ≥7 MRIDWI , CTPCBV CTA source imaging . 9 . Mismatch least 20 % measure CT CVB/MMT DWI/TTP 1 . Stroke serious head trauma within precede 3 month 2 . Major surgery serious trauma within 14 day 3 . History intracranial hemorrhage 4 . Systolic blood pressure 185 mm Hg diastolic blood pressure 110 mm Hg control aggressive measure . 5 . Rapidly improve minor symptom 6 . Symptoms suggestive subarachnoid hemorrhage . 7 . Gastrointestinal hemorrhage urinary tract hemorrhage within previous 21 day . 8 . Arterial puncture noncompressible site within previous 7 day 9 . Seizure onset stroke consider cause neurological symptom . 10 . Patients take anticoagulant receive heparin within 48 hour precede onset stroke elevate partialthromboplastin time , INR &gt; 1.7 platelet count 100,000/mm3 11 . Finger stick glucose 50 mg/dl ( 2.7 mmol/ Lt ) 400 mg per deciliter ( 22.2 mmol/Lt ) consider cause neurological symptom . 12 . Active internal bleeding 13 . Pregnancy woman childbearing potential ( must pregnancy test , urine blood , prior therapy ) . 14 . Lumbar puncture within 7 day . 15 . Known comorbid condition likely complicate therapy interfere patient assessment , u : heart failure stage 4 , severe dementia , endstage AIDS , pericarditis , cirrhosis know cancer . 16 . Unable obtain CTA perfusion brain study ( PWI CTP )</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>stroke</keyword>
	<keyword>ischemia</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>thrombolytic</keyword>
	<keyword>tPA</keyword>
	<keyword>rt-PA</keyword>
	<keyword>t-PA</keyword>
	<keyword>Activase®</keyword>
	<keyword>Alteplase</keyword>
	<keyword>wake-up stroke</keyword>
	<keyword>wake onset stroke</keyword>
	<keyword>sleep</keyword>
</DOC>